Wu Jimin, Hua Ya, Keep Richard F, Nakamura Takehiro, Hoff Julian T, Xi Guohua
Department of Neurosurgery, University of Michigan, Ann Arbor 48109-0532, USA.
Stroke. 2003 Dec;34(12):2964-9. doi: 10.1161/01.STR.0000103140.52838.45. Epub 2003 Nov 13.
Evidence indicates that brain injury after intracerebral hemorrhage (ICH) is due in part to the release of iron from hemoglobin. Therefore, we examined whether such iron is cleared from the brain and the effects of ICH on proteins that may alter iron release or handling: brain heme oxygenase-1, transferrin, transferrin receptor, and ferritin.
Male Sprague-Dawley rats received an infusion of 100 microL autologous whole blood into the right basal ganglia and were killed 1, 3, 7, 14, or 28 days later. Enhanced Perl's reaction was used for iron staining, and brain nonheme iron content was determined. Brain heme oxygenase-1, transferrin, transferrin receptor, and ferritin were examined by Western blot analysis and immunohistochemistry. Immunofluorescent double labeling was performed to identify which cell types express ferritin.
ICH upregulated heme oxygenase-1 levels and resulted in iron overload in the brain. A marked increase in brain nonheme iron was not cleared within 4 weeks. Brain transferrin and transferrin receptor levels were also increased. In addition, an upregulation of ICH on ferritin was of very long duration.
The iron overload and upregulation of iron-handling proteins, including transferrin, transferrin receptor, and ferritin, in the brain after ICH suggest that iron could be a target for ICH therapy.
有证据表明,脑出血(ICH)后的脑损伤部分归因于血红蛋白中铁的释放。因此,我们研究了这种铁是否从脑中清除,以及ICH对可能改变铁释放或处理的蛋白质的影响:脑血红素加氧酶-1、转铁蛋白、转铁蛋白受体和铁蛋白。
雄性Sprague-Dawley大鼠右侧基底节注入100微升自体全血,于1、3、7、14或28天后处死。采用改良的Perl反应进行铁染色,测定脑非血红素铁含量。通过蛋白质印迹分析和免疫组织化学检测脑血红素加氧酶-1、转铁蛋白、转铁蛋白受体和铁蛋白。进行免疫荧光双标记以确定哪些细胞类型表达铁蛋白。
ICH上调了血红素加氧酶-1水平,并导致脑内铁过载。脑非血红素铁的显著增加在4周内未清除。脑转铁蛋白和转铁蛋白受体水平也升高。此外,ICH对铁蛋白的上调作用持续时间很长。
ICH后脑内铁过载以及包括转铁蛋白、转铁蛋白受体和铁蛋白在内的铁处理蛋白的上调表明,铁可能是ICH治疗的一个靶点。